Otsuka Holdings
4578.T
#618
Rank
NZ$56.28 B
Marketcap
$104.15
Share price
-0.02%
Change (1 day)
70.19%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

P/E ratio for Otsuka Holdings (4578.T)

P/E ratio as of November 2024 (TTM): 25.6

According to Otsuka Holdings 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 25.6332. At the end of 2022 the company had a P/E ratio of 17.4.

P/E ratio history for Otsuka Holdings from 2010 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202217.4-3.3%
202118.011.43%
202016.2-22.31%
201920.8-29.46%
201829.523.83%
201723.8-20.06%
201629.829.95%
201522.977.2%
201412.936.13%
20139.51-33%
201214.217%
201112.1-9.83%
201013.5

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.